Download PDF

Science China Life Sciences

, Volume 54, Issue 8, pp 691–698 | Cite as

Ca2+ signalling in cardiovascular disease: the role of the plasma membrane calcium pumps

  • Elizabeth J. Cartwright
  • Delvac Oceandy
  • Clare Austin
  • Ludwig Neyses
Open Access
Reviews
First Online:
Received:
Accepted:

Abstract

The plasma membrane calcium ATPases (PMCA) are a family of genes which extrude Ca2+ from the cell and are involved in the maintenance of intracellular free calcium levels and/or with Ca2+ signalling, depending on the cell type. In the cardiovascular system, Ca2+ is not only essential for contraction and relaxation but also has a vital role as a second messenger in signal transduction pathways. A complex array of mechanisms regulate intracellular free calcium levels in the heart and vasculature and a failure in these systems to maintain normal Ca2+ homeostasis has been linked to both heart failure and hypertension. This article focuses on the functions of PMCA, in particular isoform 4 (PMCA4), in the heart and vasculature and the reported links between PMCAs and contractile function, cardiac hypertrophy, cardiac rhythm and sudden cardiac death, and blood pressure control and hypertension. It is becoming clear that this family of calcium extrusion pumps have essential roles in both cardiovascular health and disease.

Keywords

plasma membrane calcium/calmodulin-dependent ATPase Ca2+ homeostasis Ca2+ signalling heart failure hypertension 
Download to read the full article text

References

  1. 1.
    Lloyd-Jones D M, Larson M G, Leip E P, et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation, 2002, 106: 3068–3072, 12473553, 10.1161/01.CIR.0000039105.49749.6FPubMedCrossRefGoogle Scholar
  2. 2.
    Bleumink G S, Knetsch A M, Sturkenboom M C, et al. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure. The Rotterdam Study. Eur Heart J, 2004, 25: 1614–1619PubMedCrossRefGoogle Scholar
  3. 3.
    Bers D M. Cardiac excitation-contraction coupling. Nature, 2002, 415: 198–205, 11805843, 10.1038/415198a, 1:CAS:528:DC%2BD38Xms1Whsg%3D%3DPubMedCrossRefGoogle Scholar
  4. 4.
    Frank K F, Bolck B, Brixius K, et al. Modulation of SERCA: implications for the failing human heart. Basic Res Cardiol, 2002, 97: 172–178, 10.1007/s003950200033Google Scholar
  5. 5.
    Pieske B, Maier L S, Piacentino V, et al. Rate dependence of [Na+]i and contractility in nonfailing and failing human myocardium. Circulation, 2002, 106: 447–453, 12135944, 10.1161/01.CIR.0000023042.50192.F4, 1:CAS:528:DC%2BD38XmsVagurw%3DPubMedCrossRefGoogle Scholar
  6. 6.
    Toischer K, Lehnart S E, Tenderich G, et al. K201 improves aspects of the contractile performance of human failing myocardium via reduction in Ca(2+) leak from the sarcoplasmic reticulum. Basic Res Cardiol, 2010, 105: 279–287, 19718543, 10.1007/s00395-009-0057-8, 1:CAS:528:DC%2BC3cXnvFWktA%3D%3DPubMedPubMedCentralCrossRefGoogle Scholar
  7. 7.
    Qi M, Shannon T R, Euler D E, et al. Downregulation of sarcoplasmic reticulum Ca(2+)-ATPase during progression of left ventricular hypertrophy. Am J Physiol, 1997, 272: H2416–2424, 9176313, 1:CAS:528:DyaK2sXjsFWgtLc%3DPubMedGoogle Scholar
  8. 8.
    Davia K, Davies C H, Harding S E. Effects of inhibition of sarcoplasmic reticulum calcium uptake on contraction in myocytes isolated from failing human ventricle. Cardiovasc Res, 1997, 33: 88–97, 9059532, 10.1016/S0008-6363(96)00187-3, 1:CAS:528:DyaK2sXovV2nsw%3D%3DPubMedCrossRefGoogle Scholar
  9. 9.
    Borlak J, Thum T. Hallmarks of ion channel gene expression in end-stage heart failure. FASEB J, 2003, 17: 1592–1608, 12958166, 10.1096/fj.02-0889com, 1:CAS:528:DC%2BD3sXntlSrs7o%3DPubMedCrossRefGoogle Scholar
  10. 10.
    Marx S O, Marks A R. Regulation of the ryanodine receptor in heart failure. Basic Res Cardiol, 2002, 97: I49–151, 12479234, 10.1007/s003950200029PubMedGoogle Scholar
  11. 11.
    Terracciano C. Functional consequences of Na/Ca exchanger overexpression in cardiac myocytes. Ann N Y Acad Sci, 2002, 976: 520–527, 12502606, 10.1111/j.1749-6632.2002.tb04786.x, 1:CAS:528:DC%2BD3sXht1yhtbw%3DPubMedCrossRefGoogle Scholar
  12. 12.
    Carafoli E, James P, Strehler E E. Structure-function relationships in the calcium pump of plasma membranes. Prog Clin Biol Res, 1990, 332: 181–193, 2139512, 1:CAS:528:DyaK3cXlsVOlsrY%3DPubMedGoogle Scholar
  13. 13.
    Cartwright E J, Schuh K, Neyses L. Calcium transport in cardiovascular health and disease—the sarcolemmal calcium pump enters the stage. J Mol Cell Cardiol, 2005, 39: 403–406, 15946676, 10.1016/j.yjmcc.2005.04.007, 1:CAS:528:DC%2BD2MXosVCrs7Y%3DPubMedCrossRefGoogle Scholar
  14. 14.
    Olson S, Wang M G, Carafoli E, et al. Localization of two genes encoding plasma membrane Ca2(+)-transporting ATPases to human chromosomes 1q25-32 and 12q21-23. Genomics, 1991, 9: 629–641, 1674727, 10.1016/0888-7543(91)90356-J, 1:CAS:528:DyaK3MXkvVKntb0%3DPubMedCrossRefGoogle Scholar
  15. 15.
    Wang M G, Yi H, Hilfiker H, et al. Localization of two genes encoding plasma membrane Ca2+ ATPases isoforms 2 (ATP2B2) and 3 (ATP2B3) to human chromosomes 3p26 p25 and Xq28, → respectively. Cytogenet Cell Genet, 1994, 67: 41–45, 8187550, 10.1159/000133794, 1:CAS:528:DyaK2MXjvVWltQ%3D%3DPubMedCrossRefGoogle Scholar
  16. 16.
    Falchetto R, Vorherr T, Carafoli E. The calmodulin-binding site of the plasma membrane Ca2+ pump interacts with the transduction domain of the enzyme. Protein Sci, 1992, 1: 1613–1621, 1339025, 10.1002/pro.5560011209, 1:CAS:528:DyaK3sXhs1CisLg%3DPubMedPubMedCentralCrossRefGoogle Scholar
  17. 17.
    Carafoli E. Biogenesis: plasma membrane calcium ATPase: 15 years of work on the purified enzyme. FASEB J, 1994, 8: 993–1002, 7926378, 1:CAS:528:DyaK2cXmvFGlsL0%3DPubMedGoogle Scholar
  18. 18.
    Di Leva F, Domi T, Fedrizzi L, et al. The plasma membrane Ca2+ ATPase of animal cells: structure, function and regulation. Arch Biochem Biophys, 2008, 476: 65–74, 18328800, 10.1016/j.abb.2008.02.026PubMedCrossRefGoogle Scholar
  19. 19.
    Strehler E E, Zacharias D A. Role of alternative splicing in generating isoform diversity among plasma membrane calcium pumps. Physiol Rev, 2001, 81: 21–50, 11152753, 1:CAS:528:DC%2BD3MXitV2kt7Y%3DPubMedGoogle Scholar
  20. 20.
    Zacharias D A, Kappen C. Developmental expression of the four plasma membrane calcium ATPase (PMCA) genes in the mouse. Biochim Biophys Acta, 1999, 1428: 397–405, 10434059, 1:CAS:528:DyaK1MXmtVWjsrw%3DPubMedCrossRefGoogle Scholar
  21. 21.
    Okunade G W, Miller M L, Pyne G J, et al. Targeted ablation of plasma membrane Ca2+-ATPase (PMCA) 1 and 4 indicates a major housekeeping function for PMCA1 and a critical role in hyperactivated sperm motility and male fertility for PMCA4. J Biol Chem, 2004, 279: 33742–33750, 15178683, 10.1074/jbc.M404628200, 1:CAS:528:DC%2BD2cXmtFOiu78%3DPubMedCrossRefGoogle Scholar
  22. 22.
    Stauffer T P, Guerini D, Carafoli E. Tissue distribution of the four gene products of the plasma membrane Ca2+ pump. A study using specific antibodies. J Biol Chem, 1995, 270: 12184–12190, 7538133, 10.1074/jbc.270.11.6056, 1:CAS:528:DyaK2MXlvVWktLY%3DPubMedCrossRefGoogle Scholar
  23. 23.
    Dumont R A, Lins U, Filoteo A G, et al. Plasma membrane Ca2+-ATPase isoform 2a is the PMCA of hair bundles. J Neurosci, 2001, 21: 5066–5078, 11438582, 1:CAS:528:DC%2BD3MXkvFSku7c%3DPubMedGoogle Scholar
  24. 24.
    Ficarella R, Di Leva F, Bortolozzi M, et al. A functional study of plasma-membrane calcium-pump isoform 2 mutants causing digenic deafness. Proc Natl Acad Sci USA, 2007, 104: 1516–1521, 17234811, 10.1073/pnas.0609775104, 1:CAS:528:DC%2BD2sXhslaktLg%3DPubMedPubMedCentralCrossRefGoogle Scholar
  25. 25.
    Reinhardt T A, Filoteo A G, Penniston J T, et al. Ca(2+)-ATPase protein expression in mammary tissue. Am J Physiol Cell Physiol, 2000, 279: C1595–1602, 11029307, 1:CAS:528:DC%2BD3cXotFaru70%3DPubMedGoogle Scholar
  26. 26.
    Stahl W L, Eakin T J, Owens J W, et al. Plasma membrane Ca(2+)-ATPase isoforms: distribution of mRNAs in rat brain by in situ hybridization. Brain Res Mol Brain Res, 1992, 16: 223–231, 1337931, 10.1016/0169-328X(92)90229-5, 1:CAS:528:DyaK3sXnslKntQ%3D%3DPubMedCrossRefGoogle Scholar
  27. 27.
    Brown B J, Hilfiker H, DeMarco S J, et al. Primary structure of human plasma membrane Ca(2+)-ATPase isoform 3. Biochim Biophys Acta, 1996, 1283: 10–13, 8765088, 10.1016/0005-2736(96)00108-3PubMedCrossRefGoogle Scholar
  28. 28.
    Greeb J, Shull G E. Molecular cloning of a third isoform of the calmodulin-sensitive plasma membrane Ca2+-transporting ATPase that is expressed predominantly in brain and skeletal muscle. J Biol Chem, 1989, 264: 18569–18576, 2530223, 1:CAS:528:DyaK3cXhvFaqsro%3DPubMedGoogle Scholar
  29. 29.
    Kamagate A, Herchuelz A, Bollen A, et al. Expression of multiple plasma membrane Ca(2+)-ATPases in rat pancreatic islet cells. Cell Calcium, 2000, 27: 231–246, 10858669, 10.1054/ceca.2000.0116, 1:CAS:528:DC%2BD3cXjsFeksLc%3DPubMedCrossRefGoogle Scholar
  30. 30.
    Brandt P, Neve R L, Kammesheidt A, et al. Analysis of the tissue-specific distribution of mRNAs encoding the plasma membrane calcium-pumping ATPases and characterization of an alternately spliced form of PMCA4 at the cDNA and genomic levels. J Biol Chem, 1992, 267: 4376–4385, 1531651, 1:CAS:528:DyaK3sXhs1Gks7w%3DPubMedGoogle Scholar
  31. 31.
    Howard A, Legon S, Walters J R. Human and rat intestinal plasma membrane calcium pump isoforms. Am J Physiol, 1993, 265: G917–925, 7694502, 1:STN:280:DyaK2c%2Fls12kug%3D%3DPubMedGoogle Scholar
  32. 32.
    Jones S, Solomon A, Sanz-Rosa D, et al. The plasma membrane calcium ATPase (PMCA) modulates calcium homeostasis, intracellular signalling events and function in platelets. J Thromb Haemost, 2010, 8: 2766–2774, 20880258, 10.1111/j.1538-7836.2010.04076.x, 1:CAS:528:DC%2BC3MXhtFGgur4%3DPubMedCrossRefGoogle Scholar
  33. 33.
    Oceandy D, Cartwright EJ, Emerson M, et al. Neuronal nitric oxide synthase signaling in the heart is regulated by the sarcolemmal calcium pump 4b. Circulation, 2007, 115: 483–492, 17242280, 10.1161/CIRCULATIONAHA.106.643791, 1:CAS:528:DC%2BD2sXnvF2mtQ%3D%3DPubMedCrossRefGoogle Scholar
  34. 34.
    Pande J, Mallhi K K, Sawh A, et al. Aortic smooth muscle and endothelial plasma membrane Ca2+ pump isoforms are inhibited differently by the extracellular inhibitor caloxin 1b1. Am J Physiol Cell Physiol, 2006, 290: C1341–1349, 16452157, 10.1152/ajpcell.00573.2005, 1:CAS:528:DC%2BD28XkvFKmtLc%3DPubMedCrossRefGoogle Scholar
  35. 35.
    Schuh K, Cartwright E J, Jankevics E, et al. Plasma membrane Ca2+ ATPase 4 is required for sperm motility and male fertility. J Biol Chem, 2004, 279: 28220–28226, 15078889, 10.1074/jbc.M312599200, 1:CAS:528:DC%2BD2cXlt1Cltbo%3DPubMedCrossRefGoogle Scholar
  36. 36.
    Schultz J M, Yang Y, Caride A J, et al. Modification of human hearing loss by plasma-membrane calcium pump PMCA2. N Engl J Med, 2005, 352: 1557–1564, 15829536, 10.1056/NEJMoa043899, 1:CAS:528:DC%2BD2MXjtFGntrc%3DPubMedCrossRefGoogle Scholar
  37. 37.
    VanHouten J, Sullivan C, Bazinet C, et al. PMCA2 regulates apoptosis during mammary gland involution and predicts outcome in breast cancer. Proc Natl Acad Sci USA, 2010, 107: 11405–11410, 20534448, 10.1073/pnas.0911186107, 1:CAS:528:DC%2BC3cXot1ahu78%3DPubMedPubMedCentralCrossRefGoogle Scholar
  38. 38.
    Ueda K, Valdivia C, Medeiros-Domingo A, et al. Syntrophin mutation associated with long QT syndrome through activation of the nNOS-SCN5A macromolecular complex. Proc Natl Acad Sci USA, 2008, 105: 9355–9360, 18591664, 10.1073/pnas.0801294105, 1:CAS:528:DC%2BD1cXosFars78%3DPubMedPubMedCentralCrossRefGoogle Scholar
  39. 39.
    Arking D E, Pfeufer A, Post W, et al. A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization. Nat Genet, 2006, 38: 644–651, 16648850, 10.1038/ng1790, 1:CAS:528:DC%2BD28XltVOhtbs%3DPubMedCrossRefGoogle Scholar
  40. 40.
    Cho Y S, Go M J, Kim Y J, et al. A large-scale genome-wide association study of Asian populations uncovers genetic factors influencing eight quantitative traits. Nat Genet, 2009, 41: 527–534, 19396169, 10.1038/ng.357, 1:CAS:528:DC%2BD1MXltValt7k%3DPubMedCrossRefGoogle Scholar
  41. 41.
    Levy D, Ehret G B, Rice K, et al. Genome-wide association study of blood pressure and hypertension. Nat Genet, 2009, 41: 677–687, 19430479, 10.1038/ng.384, 1:CAS:528:DC%2BD1MXls1Cmurk%3DPubMedPubMedCentralCrossRefGoogle Scholar
  42. 42.
    Tabara Y, Kohara K, Kita Y, et al. Common variants in the ATP2B1 gene are associated with susceptibility to hypertension: the Japanese Millennium Genome Project. Hypertension, 2010, 56: 973–980, 20921432, 10.1161/HYPERTENSIONAHA.110.153429, 1:CAS:528:DC%2BC3cXhtlSqu7%2FKPubMedCrossRefGoogle Scholar
  43. 43.
    Takeuchi F, Isono M, Katsuya T, et al. Blood pressure and hypertension are associated with 7 loci in the Japanese population. Circulation, 2010, 121: 2302–2309, 20479155, 10.1161/CIRCULATIONAHA.109.904664PubMedCrossRefGoogle Scholar
  44. 44.
    Kozel P J, Friedman R A, Erway L C, et al. Balance and hearing deficits in mice with a null mutation in the gene encoding plasma membrane Ca2+-ATPase isoform 2. J Biol Chem, 1998, 273: 18693–18696, 9668038, 10.1074/jbc.273.30.18693, 1:CAS:528:DyaK1cXltFGrs7w%3DPubMedCrossRefGoogle Scholar
  45. 45.
    Street V A, McKee-Johnson J W, Fonseca R C, et al. Mutations in a plasma membrane Ca2+-ATPase gene cause deafness in deafwaddler mice. Nat Genet, 1998, 19: 390–394, 9697703, 10.1038/1284, 1:CAS:528:DyaK1cXlt1CisrY%3DPubMedCrossRefGoogle Scholar
  46. 46.
    Takahashi K, Kitamura K. A point mutation in a plasma membrane Ca(2+)-ATPase gene causes deafness in Wriggle Mouse Sagami. Biochem Biophys Res Commun, 1999, 261: 773–778, 10441500, 10.1006/bbrc.1999.1102, 1:CAS:528:DyaK1MXltVagsLk%3DPubMedCrossRefGoogle Scholar
  47. 47.
    Mohamed T M, Oceandy D, Prehar S, et al. Specific role of neuronal nitric-oxide synthase when tethered to the plasma membrane calcium pump in regulating the beta-adrenergic signal in the myocardium. J Biol Chem, 2009, 284: 12091–12098, 19278978, 10.1074/jbc.M809112200, 1:CAS:528:DC%2BD1MXltVCmtbc%3DPubMedPubMedCentralCrossRefGoogle Scholar
  48. 48.
    Wu X, Chang B, Blair N S, et al. Plasma membrane Ca2+-ATPase isoform 4 antagonizes cardiac hypertrophy in association with calcineurin inhibition in rodents. J Clin Invest, 2009, 119: 976–985, 19287093, 1:CAS:528:DC%2BD1MXktlSntL4%3DPubMedPubMedCentralGoogle Scholar
  49. 49.
    Bendall J K, Damy T, Ratajczak P, et al. Role of myocardial neuronal nitric oxide synthase-derived nitric oxide in beta-adrenergic hyporesponsiveness after myocardial infarction-induced heart failure in rat. Circulation, 2004, 110: 2368–2375, 15466641, 10.1161/01.CIR.0000145160.04084.AC, 1:CAS:528:DC%2BD2cXosVSlsL4%3DPubMedCrossRefGoogle Scholar
  50. 50.
    Casadei B. The emerging role of neuronal nitric oxide synthase in the regulation of myocardial function. Exp Physiol, 2006, 91: 943–955, 16990366, 10.1113/expphysiol.2006.035493, 1:CAS:528:DC%2BD28XhtlGhsL7KPubMedCrossRefGoogle Scholar
  51. 51.
    Zimmet J M, Hare J M. Nitroso-redox interactions in the cardiovascular system. Circulation, 2006, 114: 1531–1544, 17015805, 10.1161/CIRCULATIONAHA.105.605519PubMedCrossRefGoogle Scholar
  52. 52.
    Dawson D, Lygate C A, Zhang M H, et al. nNOS gene deletion exacerbates pathological left ventricular remodeling and functional deterioration after myocardial infarction. Circulation, 2005, 112: 3729–3737, 16344403, 10.1161/CIRCULATIONAHA.105.539437, 1:CAS:528:DC%2BD2MXht1yitb7JPubMedCrossRefGoogle Scholar
  53. 53.
    Loyer X, Gomez A M, Milliez P, et al. Cardiomyocyte overexpression of neuronal nitric oxide synthase delays transition toward heart failure in response to pressure overload by preserving calcium cycling. Circulation, 2008, 117: 3187–3198, 18541744, 10.1161/CIRCULATIONAHA.107.741702, 1:CAS:528:DC%2BD1cXnt1ehs74%3DPubMedCrossRefGoogle Scholar
  54. 54.
    Cartwright E J, Oceandy D, Neyses L. Physiological implications of the interaction between the plasma membrane calcium pump and nNOS. Pflugers Arch, 2009, 457: 665–671, 18228035, 10.1007/s00424-008-0455-z, 1:CAS:528:DC%2BD1MXjvFOhsg%3D%3DPubMedCrossRefGoogle Scholar
  55. 55.
    Schuh K, Uldrijan S, Telkamp M, et al. The plasmamembrane calmodulin-dependent calcium pump: a major regulator of nitric oxide synthase I. J Cell Biol, 2001, 155: 201–205, 11591728, 10.1083/jcb.200104131, 1:CAS:528:DC%2BD3MXnslGjur0%3DPubMedPubMedCentralCrossRefGoogle Scholar
  56. 56.
    Colella M, Grisan F, Robert V, et al. Ca2+ oscillation frequency decoding in cardiac cell hypertrophy: role of calcineurin/NFAT as Ca2+ signal integrators. Proc Natl Acad Sci USA, 2008, 105: 2859–2864, 18287024, 10.1073/pnas.0712316105, 1:CAS:528:DC%2BD1cXjtVSju7g%3DPubMedPubMedCentralCrossRefGoogle Scholar
  57. 57.
    Wilkins B J, Dai Y S, Bueno O F, et al. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy. Circ Res, 2004, 94: 110–118, 14656927, 10.1161/01.RES.0000109415.17511.18, 1:CAS:528:DC%2BD2cXhtFSrPubMedCrossRefGoogle Scholar
  58. 58.
    Buch M H, Pickard A, Rodriguez A, et al. The sarcolemmal calcium pump inhibits the calcineurin/nuclear factor of activated T-cell pathway via interaction with the calcineurin A catalytic subunit. J Biol Chem, 2005, 280: 29479–29487, 15955804, 10.1074/jbc.M501326200, 1:CAS:528:DC%2BD2MXns1Slsrc%3DPubMedCrossRefGoogle Scholar
  59. 59.
    Crabtree G R. Generic signals and specific outcomes: signaling through Ca2+, calcineurin, and NF-AT. Cell, 1999, 96: 611–614, 10089876, 10.1016/S0092-8674(00)80571-1, 1:CAS:528:DyaK1MXitVChsr0%3DPubMedCrossRefGoogle Scholar
  60. 60.
    Kubis H P, Hanke N, Scheibe R J, et al. Ca2+ transients activate calcineurin/NFATc1 and initiate fast-to-slow transformation in a primary skeletal muscle culture. Am J Physiol Cell Physiol, 2003, 285: C56–63, 12606309, 1:CAS:528:DC%2BD3sXls1Wnt7Y%3DPubMedCrossRefGoogle Scholar
  61. 61.
    Molkentin J D, Lu J R, Antos C L, et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell, 1998, 93: 215–228, 9568714, 10.1016/S0092-8674(00)81573-1, 1:CAS:528:DyaK1cXivVygtrs%3DPubMedPubMedCentralCrossRefGoogle Scholar
  62. 62.
    Williams J C, Armesilla A L, Mohamed T M, et al. The sarcolemmal calcium pump, alpha-1 syntrophin, and neuronal nitric-oxide synthase are parts of a macromolecular protein complex. J Biol Chem, 2006, 281: 23341–23348, 16735509, 10.1074/jbc.M513341200, 1:CAS:528:DC%2BD28XotVCmtro%3DPubMedCrossRefGoogle Scholar
  63. 63.
    Beigi F, Oskouei B N, Zheng M, et al. Cardiac nitric oxide synthase-1 localization within the cardiomyocyte is accompanied by the adaptor protein, CAPON. Nitric Oxide, 2009, 21: 226–233, 19800018, 10.1016/j.niox.2009.09.005, 1:CAS:528:DC%2BD1MXhsVWqsb3JPubMedPubMedCentralCrossRefGoogle Scholar
  64. 64.
    Hammes A, Oberdorf S, Strehler E E, et al. Differentiation-specific isoform mRNA expression of the calmodulin-dependent plasma membrane Ca(2+)-ATPase. FASEB J, 1994, 8: 428–435, 8168693, 1:CAS:528:DyaK2cXivFGitLc%3DPubMedGoogle Scholar
  65. 65.
    Heagerty A M, Heerkens E H, Izzard A S. Small artery structure and function in hypertension. J Cell Mol Med, 2010, 14: 1037–1043, 20455998PubMedPubMedCentralGoogle Scholar
  66. 66.
    Schofield I, Malik R, Izzard A, et al. Vascular structural and functional changes in type 2 diabetes mellitus: evidence for the roles of abnormal myogenic responsiveness and dyslipidemia. Circulation, 2002, 106: 3037–3043, 12473548, 10.1161/01.CIR.0000041432.80615.A5PubMedCrossRefGoogle Scholar
  67. 67.
    Nieves-Cintron M, Amberg G C, Navedo M F, et al. The control of Ca2+ influx and NFATc3 signaling in arterial smooth muscle during hypertension. Proc Natl Acad Sci USA, 2008, 105: 15623–15628, 18832165, 10.1073/pnas.0808759105, 1:CAS:528:DC%2BD1cXht1GitbvIPubMedPubMedCentralCrossRefGoogle Scholar
  68. 68.
    Wellman G C, Cartin L, Eckman D M, et al. Membrane depolarization, elevated Ca(2+) entry, and gene expression in cerebral arteries of hypertensive rats. Am J Physiol, 2001, 281: H2559–2567, 1:CAS:528:DC%2BD3MXptlKns7o%3DGoogle Scholar
  69. 69.
    Hermsmeyer K, Erne P. Cellular calcium regulation in hypertension. Am J Hypertens, 1989, 2: 655–658, 2550033, 1:CAS:528:DyaL1MXmt12rsbo%3DPubMedCrossRefGoogle Scholar
  70. 70.
    McCarron J G, Bradley K N, MacMillan D, et al. The sarcoplasmic reticulum, Ca2+ trapping, and wave mechanisms in smooth muscle. News Physiol Sci, 2004, 19: 138–147, 15143210, 1:CAS:528:DC%2BD2cXlsFaqsLY%3DPubMedGoogle Scholar
  71. 71.
    McGeown J G. Interactions between inositol 1,4,5-trisphosphate receptors and ryanodine receptors in smooth muscle: one store or two? Cell Calcium, 2004, 35: 613–619, 15110151, 10.1016/j.ceca.2004.01.016, 1:CAS:528:DC%2BD2cXjsVWks7Y%3DPubMedCrossRefGoogle Scholar
  72. 72.
    Ganitkevich V, Hasse V, Pfitzer G. Ca2+-dependent and Ca2+-independent regulation of smooth muscle contraction. J Muscle Res Cell Motil, 2002, 23: 47–52, 12363284, 10.1023/A:1019956529549, 1:CAS:528:DC%2BD38Xms1ektL4%3DPubMedCrossRefGoogle Scholar
  73. 73.
    Shaw L, O’Neill S, Jones C J, et al. Comparison of U46619-, endothelin-1- or phenylephrine-induced changes in cellular Ca2+ profiles and Ca2+ sensitisation of constriction of pressurised rat resistance arteries. Br J Pharmacol, 2004, 141: 678–688, 14744813, 10.1038/sj.bjp.0705647, 1:CAS:528:DC%2BD2cXivVCmurs%3DPubMedPubMedCentralCrossRefGoogle Scholar
  74. 74.
    Gollasch M, Lohn M, Furstenau M, et al. Ca2+ channels, ‘quantized’ Ca2+ release, and differentiation of myocytes in the cardiovascular system. J Hypertens, 2000, 18: 989–998, 10953988, 10.1097/00004872-200018080-00001, 1:CAS:528:DC%2BD3cXmsVWhs7o%3DPubMedCrossRefGoogle Scholar
  75. 75.
    McCarron J G, Chalmers S, Bradley K N, et al. Ca2+ microdomains in smooth muscle. Cell Calcium, 2006, 40: 461–493, 17069885, 10.1016/j.ceca.2006.08.010, 1:CAS:528:DC%2BD28XhtFKmt7jFPubMedCrossRefGoogle Scholar
  76. 76.
    Shaw L, Sweeney M A, O’Neill S C, et al. Caveolae and sarcoplasmic reticular coupling in smooth muscle cells of pressurised arteries: the relevance for Ca2+ oscillations and tone. Cardiovasc Res, 2006, 69: 825–835, 16464442, 10.1016/j.cardiores.2005.12.016, 1:CAS:528:DC%2BD28XhsF2iu70%3DPubMedCrossRefGoogle Scholar
  77. 77.
    Berridge M J, Bootman M D, Roderick H L. Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol, 2003, 4: 517–529, 12838335, 10.1038/nrm1155, 1:CAS:528:DC%2BD3sXltVWmsr8%3DPubMedCrossRefGoogle Scholar
  78. 78.
    Floyd R, Wray S. Calcium transporters and signalling in smooth muscles. Cell Calcium, 2007, 42: 467–476, 17624426, 10.1016/j.ceca.2007.05.011, 1:CAS:528:DC%2BD2sXpsFKltLo%3DPubMedCrossRefGoogle Scholar
  79. 79.
    Poburko D, Kuo K H, Dai J, et al. Organellar junctions promote targeted Ca2+ signaling in smooth muscle: why two membranes are better than one. Trends Pharmacol Sci, 2004, 25: 8–15, 14723973, 10.1016/j.tips.2003.10.011, 1:CAS:528:DC%2BD2cXjtFeiuw%3D%3DPubMedCrossRefGoogle Scholar
  80. 80.
    Bers D M. Calcium fluxes involved in control of cardiac myocyte contraction. Circ Res, 2000, 87: 275–281, 10948060, 1:CAS:528:DC%2BD3cXmtFCkurk%3DPubMedCrossRefGoogle Scholar
  81. 81.
    Kamishima T, McCarron J G. Ca2+ removal mechanisms in rat cerebral resistance size arteries. Biophys J, 1998, 75: 1767–1773, 9746518, 10.1016/S0006-3495(98)77618-0, 1:CAS:528:DyaK1cXmsVCktLo%3DPubMedPubMedCentralCrossRefGoogle Scholar
  82. 82.
    Matthew A, Shmygol A, Wray S. Ca2+ entry, efflux and release in smooth muscle. Biol Res, 2004, 37: 617–624, 15709690, 10.4067/S0716-97602004000400017, 1:STN:280:DC%2BD2M%2FotVGqsQ%3D%3DPubMedCrossRefGoogle Scholar
  83. 83.
    Liu L, Ishida Y, Okunade G, et al. Role of plasma membrane Ca2+-ATPase in contraction-relaxation processes of the bladder: evidence from PMCA gene-ablated mice. Am J Physiol Cell Physiol, 2006, 290: C1239–1247, 16291816, 10.1152/ajpcell.00440.2005, 1:CAS:528:DC%2BD28Xks1SmtL0%3DPubMedCrossRefGoogle Scholar
  84. 84.
    Schuh K, Quaschning T, Knauer S, et al. Regulation of vascular tone in animals overexpressing the sarcolemmal calcium pump. J Biol Chem, 2003, 278: 41246–41252, 12900399, 10.1074/jbc.M307606200, 1:CAS:528:DC%2BD3sXotFWgur0%3DPubMedCrossRefGoogle Scholar
  85. 85.
    Gros R, Afroze T, You X M, et al. Plasma membrane calcium ATPase overexpression in arterial smooth muscle increases vasomotor responsiveness and blood pressure. Circ Res, 2003, 93: 614–621, 12933703, 10.1161/01.RES.0000092142.19896.D9, 1:CAS:528:DC%2BD3sXnsFSgsrY%3DPubMedCrossRefGoogle Scholar
  86. 86.
    Pande J, Szewczyk M M, Kuszczak I, et al. Functional effects of caloxin 1c2, a novel engineered selective inhibitor of plasma membrane Ca(2+)-pump isoform 4, on coronary artery. J Cell Mol Med, 2008, 12: 1049–1060, 18494944, 10.1111/j.1582-4934.2008.00140.x, 1:CAS:528:DC%2BD1cXotlCrurs%3DPubMedPubMedCentralCrossRefGoogle Scholar
  87. 87.
    Holton M, Mohamed T M, Oceandy D, et al. Endothelial nitric oxide synthase activity is inhibited by the plasma membrane calcium ATPase in human endothelial cells. Cardiovasc Res, 2010, 87: 440–448, 20211863, 10.1093/cvr/cvq077, 1:CAS:528:DC%2BC3cXptVylur0%3DPubMedPubMedCentralCrossRefGoogle Scholar
  88. 88.
    Mohamed T M, Baudoin-Stanley F M, Abou-Leisa R, et al. Measurement of plasma membrane calcium-calmodulin-dependent ATPase (PMCA) activity. Methods Mol Biol, 2010, 637: 333–342, 20419444, 10.1007/978-1-60761-700-6_18, 1:CAS:528:DC%2BC3cXos1Crs70%3DPubMedCrossRefGoogle Scholar

Copyright information

© The Author(s) 2011

This article is published under license to BioMed Central Ltd. Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution and reproduction in any medium, provided the original author(s) and source are credited.

Authors and Affiliations

  • Elizabeth J. Cartwright
    • 1
  • Delvac Oceandy
    • 1
  • Clare Austin
    • 1
  • Ludwig Neyses
    • 1
  1. 1.Cardiovascular Medicine Research Group, Manchester Academic Health Science CentreUniversity of ManchesterManchesterUK

Personalised recommendations